Semler Scientific, Inc.

NasdaqCM SMLR

Semler Scientific, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2024: USD 58.94 M

Semler Scientific, Inc. Revenue is USD 58.94 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -11.93% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Semler Scientific, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 66.92 M, a 22.94% change year over year.
  • Semler Scientific, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 54.43 M, a 1.63% change year over year.
  • Semler Scientific, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 53.56 M, a 50.10% change year over year.
  • Semler Scientific, Inc. Revenue for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 35.68 M, a 20.63% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
NasdaqCM: SMLR

Semler Scientific, Inc.

CEO Dr. Douglas Murphy-Chutorian M.D.
IPO Date Feb. 21, 2014
Location United States
Headquarters 2340-2348 Walsh Avenue
Employees 92
Sector Health Care
Industries
Description

Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.

Similar companies

INGN

Inogen, Inc.

USD 10.62

2.81%

OFIX

Orthofix Medical Inc.

USD 17.51

0.81%

NPCE

NeuroPace, Inc.

USD 11.84

-2.23%

SRDX

Surmodics, Inc.

USD 35.55

-0.81%

AORT

Artivion, Inc.

USD 29.68

1.16%

TMDX

TransMedics Group, Inc.

USD 62.54

-2.36%

TELA

TELA Bio, Inc.

USD 2.74

-1.44%

CVRX

CVRx, Inc.

USD 16.15

7.38%

LIVN

LivaNova PLC

USD 47.63

0.66%

DCTH

Delcath Systems, Inc.

USD 12.69

-0.78%

ELMD

Electromed, Inc.

USD 31.05

1.90%

APYX

Apyx Medical Corporation

USD 1.43

-4.03%

KIDS

OrthoPediatrics Corp.

USD 23.55

-5.80%

LUNG

Pulmonx Corporation

USD 6.84

-2.98%

StockViz Staff

January 15, 2025

Any question? Send us an email